"I have one of the most fun jobs in Ascension Health and there are more than 120,000 employees."

He joined having worked at venture firm TVM Capital as a general partner since 2007.

"I was brought on to make this as significant an undertaking as it could be and that is the way it has played out."

In his present role as vice-president of corporate business development at Eli Lilly, he oversees acquisitions, private equity deals, partnering and corporate venturing.

Carlsen is on the board of PTC Therapeutics and Santaris Pharma, and was previously a board member of 7TM Pharma and Arpida.

An undisclosed, private, US-based investment company will invest up to $15m in milestone related equity in Keddem, with Compugen maintaining a minority interest

RTP was part of consortia investing $5.25m in MabVax Therapeutics and $6.2m in Datadog.

The University of Cambridge is making its first three investments into UoC spinouts through its new Enterprise Fund.